Baudax Bio to Report Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 9, 2020
November 02, 2020 07:05 ET
|
Baudax Bio, Inc.
MALVERN, Pa., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that it will report third...
Baudax Bio Provides Commercial and Corporate Update
October 20, 2020 07:00 ET
|
Baudax Bio, Inc.
ANJESO® Launch Underway; Over 50 Institutions have Added ANJESO to Their Formularies ANJESO Users Giving Highly Positive Feedback; Average Order Size Has Increased 75% Since Launch, Despite Ongoing...
Baudax Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 02, 2020 16:05 ET
|
Baudax Bio, Inc.
MALVERN, Pa., Oct. 02, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that the Compensation...
Baudax Bio to Present at Oppenheimer Fall Healthcare Life Sciences & Medtech Summit
September 18, 2020 07:35 ET
|
Baudax Bio, Inc.
MALVERN, Pa., Sept. 18, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced Gerri Henwood, the...
Baudax Bio Awarded Group Purchasing Agreement with Premier Inc. for ANJESO®
August 25, 2020 16:05 ET
|
Baudax Bio, Inc.
MALVERN, Pa., Aug. 25, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that it has been awarded a...
Baudax Bio Appoints Arnold Baskies, M.D. and Andrew Drechsler to Board of Directors
August 20, 2020 17:57 ET
|
Baudax Bio, Inc.
MALVERN, Pa., Aug. 20, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that Arnold Baskies, M.D....
Baudax Bio Reports Second Quarter 2020 Financial Results
August 10, 2020 07:15 ET
|
Baudax Bio, Inc.
Commenced Commercial Launch of ANJESO® in the U.S. Awarded J-Code from CMS Executed Contract with a top National GPO for hospital purchases, Vizient, and one of the top 3 IDNs Nationally ...
Baudax Bio to Report Second Quarter 2020 Financial Results and Host Conference Call and Webcast on August 10, 2020
August 06, 2020 16:05 ET
|
Baudax Bio, Inc.
MALVERN, Pa., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that it will report second...
Baudax Bio Secures Permanent J-Code (J1738) for ANJESO® from Centers for Medicare and Medicaid Services
August 06, 2020 07:00 ET
|
Baudax Bio, Inc.
MALVERN, Pa., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that the Centers for...
Baudax Bio Announces Presentation of New Phase IIIb ANJESO® Data at the American Society of Colon and Rectal Surgeons 2020 Annual Scientific Meeting
July 30, 2020 16:05 ET
|
Baudax Bio, Inc.
MALVERN, Pa., July 30, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced a virtual poster...